Article metrics

Download PDFPDF

618 Phase 1 clinical trial evaluating the safety, biologic and anti-tumor activity of the novel STING agonist IMSA101 administered both as monotherapy and in combination with PD-(L)1 checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: November 2023 to March 2024

AbstractFullPdf
Nov 2023284032
Dec 202379016
Jan 20248806
Feb 20247608
Mar 2024148023
Total675085